![James Flynn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Flynn
Directeur/Membre du Conseil chez
LITE STRATEGY, INC.
Fortune : 181 800 $ au 30/09/2026
Profil
Mr. James Flynn, CFA, is an Independent Director at RiceBran Technologies, an Independent Non-Executive Director at Lite Strategy, Inc. and a Managing Member & Portfolio Manager at Nerium Capital LLC.
He is on the Board of Directors at Synlogic, Inc., RiceBran Technologies, Lite Strategy, Inc. and Axiom Healthcare Strategies LLC.
Mr. Flynn was previously employed as an Independent Director by ARCA biopharma, Inc. and a Manager-Healthcare Portfolio by Amici Capital LLC.
He also served on the board at Axiom Health, Inc. He received his undergraduate degree from Massachusetts Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LITE STRATEGY INC 0,41 % | 22/09/2026 | 125 000 ( 0,41 % ) | 165 000 $ | 30/09/2026 |
SYNLOGIC INC 0,12 % | 31/03/2026 | 15 000 ( 0,12 % ) | 16 800 $ | 30/09/2026 |
Postes actifs de James Flynn
| Sociétés | Poste | Début |
|---|---|---|
| LITE STRATEGY, INC. | Directeur/Membre du Conseil | 31/10/2023 |
| RICEBRAN TECHNOLOGIES | Directeur/Membre du Conseil | 03/01/2024 |
| SYNLOGIC, INC. | Directeur/Membre du Conseil | 19/03/2024 |
Axiom Healthcare Strategies LLC
 Axiom Healthcare Strategies LLC Medical/Nursing ServicesHealth Services Provides healthcare services | Directeur/Membre du Conseil | 01/07/2022 |
Nerium Capital LLC | Fondateur | 01/01/2021 |
Anciens postes connus de James Flynn
| Sociétés | Poste | Fin |
|---|---|---|
Amici Capital LLC
 Amici Capital LLC Investment ManagersFinance Amici Capital invests in equities both long and short. They practice a flexible, value-oriented approach that encompasses investments in the publicly traded securities of companies in a broad spectrum of industries and geographies. The firm seeks to have a core long-term, large investment in relatively few stocks on the long side, taking advantage of in-depth knowledge of favored companies, with a complement on the short side that represents both significant profit opportunities and a market hedge. Amici Capital seeks to achieve strong absolute returns in all market environments, with a concurrent focus on capital preservation. | Corporate Officer/Principal | 01/01/2017 |
| ARCA BIOPHARMA | Directeur/Membre du Conseil | - |
Formation de James Flynn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
38
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Amici Capital LLC
Amici Capital LLC Investment ManagersFinance Amici Capital invests in equities both long and short. They practice a flexible, value-oriented approach that encompasses investments in the publicly traded securities of companies in a broad spectrum of industries and geographies. The firm seeks to have a core long-term, large investment in relatively few stocks on the long side, taking advantage of in-depth knowledge of favored companies, with a complement on the short side that represents both significant profit opportunities and a market hedge. Amici Capital seeks to achieve strong absolute returns in all market environments, with a concurrent focus on capital preservation. | Finance |
RiceBran Technologies
 RiceBran Technologies Agricultural Commodities/MillingProcess Industries Engages in rice milling for producing, processing and marketing of natural and nutrient dense products derived from grains | Process Industries |
MEI Pharma, Inc.
 MEI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
ARCA biopharma, Inc.
 ARCA biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Health Technology |
Synlogic, Inc.
 Synlogic, Inc. Financial ConglomeratesFinance Operates as a shell company | Finance |
Nerium Capital LLC | |
Axiom Healthcare Strategies LLC
Axiom Healthcare Strategies LLC Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
